Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Implications for Clinical Trial Design

被引：0
|
作者：
Montorsi, Francesco [1 ]
Moschini, Marco [1 ]
Necchi, Andrea [1 ]
Deho, Federico [1 ]
Gandaglia, Giorgio [1 ]
Briganti, Alberto [1 ]
机构：
[1] IRCCS Osped San Raffaele, Div Oncol, Unit Urol, Urol Res Inst, Milan, Italy
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1528 / 1528
页数：1
相关论文
共 50 条
  • [31] Discontinuance of Bacille Calmette-Guerin Instillation Therapy for Nonmuscle-invasive Bladder Cancer Has Negative Effect on Tumor Recurrence
    Takeda, Toshikazu
    Kikuchi, Eiji
    Yuge, Kazuyuki
    Matsumoto, Kazuhiro
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    UROLOGY, 2009, 73 (06) : 1318 - 1322
  • [32] EXTERNAL VALIDATION OF EORTC AND CUETO SCORING MODELS TO PREDICT RECURRENCE AND PROGRESSION IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUERIN
    Kohjimoto, Yasuo
    Kusumoto, Hiroki
    Matsumura, Nagahide
    Inagaki, Takeshi
    Hara, Isao
    JOURNAL OF UROLOGY, 2012, 187 (04): : E716 - E717
  • [33] Phase I trial of intravesical Bacillus Calmette-Guerin combined with intravenous Pembrolizumab in high grade nonmuscle invasive bladder cancer
    Alanee, Shaheen
    El Zawahry, Ahmed
    Sana, Sherjeel
    McVary, Kevin
    Robinson, Kathy
    Rao, Krishna A.
    CANCER RESEARCH, 2019, 79 (13)
  • [34] PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUERIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN HIGH GRADE NONMUSCLE INVASIVE BLADDER CANCER
    Alanee, Shaheen
    El-Zawahry, Ahmed
    McVary, Kevin
    Deebajah, Mustafa
    Sana, Sherjeel
    Robinson, Kathy
    Rao, Krishna
    JOURNAL OF UROLOGY, 2019, 201 (04): : E620 - E621
  • [35] Re: The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Babjuk, Marko
    EUROPEAN UROLOGY, 2015, 67 (04) : 815 - 815
  • [36] Diminished Efficacy of Bacille Calmette-Guerin Among Elderly Patients with Nonmuscle Invasive Bladder Cancer
    Margel, David
    Alkhateeb, Sultan S.
    Finelli, Antonio
    Fleshner, Neil
    UROLOGY, 2011, 78 (04) : 848 - 854
  • [37] Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guerin
    Wei, Hua
    Kamat, Ashish
    Chen, Meng
    Ke, Hung-Lung
    Chang, David W.
    Yin, Jikai
    Grossman, H. Barton
    Dinney, Colin P.
    Wu, Xifeng
    PLOS ONE, 2012, 7 (06):
  • [38] A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer.
    Escano, De Jesus Manuel R.
    Sjoberg, Daniel D.
    McCarter, Melissa
    McGill, Marlena
    Goh, Alvin
    Donahue, Timothy F.
    Donat, Machele S.
    Cha, Eugene K.
    Herr, Harry W.
    Meraney, Anoop M.
    Al-Ahmadie, Hikmat A.
    Solit, David B.
    Dalbagni, Guido
    Bajorin, Dean F.
    Bochner, Bernard H.
    Pietzak, Eugene J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [39] ELUCIDATING THE RESPONSE RATES TO CONTINUED BACILLUS CALMETTE-GUERIN (BCG) IN PATIENTS WITH BCG EXPOSED BLADDER CANCER: IMPLICATIONS FOR CLINICAL TRIAL DESIGN
    Myers, Amanda A.
    Tan, Wei Shen
    Grajales, Valentina
    Hwang, Hyunsoo
    Bree, Kelly K.
    Navai, Neema
    Lee, Byron H.
    Dinney, Colin P. N.
    Kamat, Ashish M.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E627 - E627
  • [40] Intravesical Bacillus Calmette-Guerin Outcomes in Patients With Bladder Cancer and Asymptomatic Bacteriuria
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2012, 187 (02): : 435 - 437
12345